CVS launches new venture in biosimilar drug experiment August 24, 2023 San Francisco Biotechnology Network News News, Syndication Comments Off on CVS launches new venture in biosimilar drug experiment The subsidiary, called Cordavis, will work directly with manufacturers to market or co-produce low-cost biologic drugs, starting with Novartis’ Humira copy. Click here to view original post